24 Jul, EOD - Indian

SENSEX 80148.88 (-0.35)

Nifty 50 24413.5 (-0.27)

Nifty Bank 51317 (-0.89)

Nifty IT 40115.05 (0.18)

Nifty Midcap 100 56872.75 (1.04)

Nifty Next 50 71844.65 (0.30)

Nifty Pharma 20908.5 (0.74)

Nifty Smallcap 100 18723.5 (1.76)

24 Jul, EOD - Global

NIKKEI 225 39154.85 (-1.11)

HANG SENG 17311.05 (-0.91)

DOW JONES 40023.82 (-0.83)

S&P 5459.06 (-1.74)

Arvee Laboratories (India) Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 535050 | NSE Symbol : ARVEE | ISIN : INE006Z01016 | Industry : Chemicals |


Board Meeting
Announcement Date Date Of Meeting Purpose
24-Jun-2024 24-Jun-2024 Arvee Laboratories (India) Limited has informed the Exchange regarding Appointment of Mr Praveenkuma as Non- Executive Director of the company w.e.f. Jun 24, 2024.
05-May-2024 17-May-2024 To consider and approve the financial results for the period ended March 31, 2024 and other business matters. Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2024. Arvee Laboratories (India) Limited has informed the Exchange regarding Board meeting held on May 17, 2024. (As Per NSE Announcement Dated on: 17/05/2024)
27-Jan-2024 13-Feb-2024 To consider and approve the financial results for the period ended December 31, 2023. ARVEE : 13-Feb-2024 : The Company has informed the Exchange that a Board meeting to be held on February 09, 2024 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on February 13, 2024, To consider and approve the financial results for the period ended December 31, 2023 and other business matters. (As Per NSE Announcement Dated on: 05/02/2024) Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended December 31, 2023. (As Per NSE Announcement Dated on: 13/02/2024)
24-Oct-2023 07-Nov-2023 To consider and approve the financial results for the period ended September 30, 2023 and other business matters Arvee Laboratories (India) Limited has informed the Exchange regarding Board meeting held on November 07, 2023. (As Per NSE Announcement Dated on: 07/11/2023)
29-Jul-2023 11-Aug-2023 To consider and approve the financial results for the period ended Jun 30, 2023 and other business matters ARVEE LABORATORIES (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 11-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2023 . (As Per BSE Announcement Dated on 05/08/2023) Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended June 30, 2023. Arvee Laboratories (India) Limited has informed the Exchange regarding Board meeting held on August 11, 2023. (As Per NSE Announcement Dated on 11/08/2023)
26-Apr-2023 05-May-2023 To consider and approve the financial results for the period ended March 31, 2023 and other business matters Arvee Laboratories (India) Limited has informed the Exchange regarding '1. Approve and take on record the audited consolidated financial results of the Company as per Indian Accounting Standards (INDAS) for the quarter and year ending March 31, 2023 including Cash flow Statement for the period ended on 31st March, 2023. 2. Approved the Declaration of Unmodified Opinion3. Approve the Related Party Transactions for the half year ended on 31st March, 2023.4. Re-appointment of Internal Auditors5. Re-appointment of M/s. Jalan Alkesh & Associates, Company Secretaries, Ahmedabad for the year 2023 2024 and thereafter.6. Any other matter with the permission of Chair.'. (As Per NSE Announcement Dated on 26/04/2023) ARVEE LABORATORIES (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 05-May-2023 to consider financial statements for the period ended March 2023, Financial results/Other business. (As Per NSE Announcement Dated on 28/04/2023) Arvee Laboratories (India) Limited has informed the Exchange regarding Outcome of Board Meeting held on May 05, 2023. Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2023. (As Per NSE Announcement Dated on 05/05/2023)
23-Jan-2023 02-Feb-2023 To consider and approve the financial results for the period ended December 31, 2022 and other business matters Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended December 31, 2022. (As Per NSE Announcement Dated on 02/02/2023)
01-Nov-2022 11-Nov-2022 Arvee Laboratories (India) Limited has informed the Exchange about Board Meeting to be held on 11-Nov-2022 to consider financial statements for the period ended September 2022 and Other business matters Arvee Laboratories (India) Limited has informed the Exchange about Board Meeting held on 11-Nov-2022 to consider financial statements for the period ended September 2022 and Other business matters (As Per NSE Announcement Dated on 11.11.2022)
20-Jul-2022 02-Aug-2022 Arvee Laboratories (India) Limited has informed the Exchange about Board Meeting to be held on 02-Aug-2022 to consider financial statements for the period ended June 2022 and Other business matters Arvee Laboratories (India) Limited has informed the Exchange about Board Meeting held on 02-Aug-2022 to consider financial statements for the period ended June 2022. Also find attached herewith the limited review report issued by the auditors for the quarter ended on 30th June, 2022. (As Per NSE Announcement Dated on 02.08.2022)
17-Jun-2022 27-Jun-2022 Arvee Laboratories (India) Limited has informed the Exchange about Board Meeting to be held on 27-Jun-2022 to consider Other business matters. Amongst inter alia, other matters the following matters to be transacted :a. To Appoint Internal Auditorsb. To Appoint Secretarial Auditorsc. To Re-appoint Mr. Shalin Sudhakarbhai Patel, as a Managing Director of the Companyd. To Re-appoint Mr. Shalin Bharat Chokshi as a Whole Time Director of the Companye. To Appoint Scrutiniser f. To fix the Date, Time and Venue of Annual General Meeting of the Company for the year ended on 31st March, 2022.g. To authorize the Board of Directors to make investments or give loan or provide security. h. To consider any other matter with the permission of Chair. Arvee Laboratories (India) Limited has informed the Exchange about 1.resignation of VISHAL NITIN MEHTA as Independent Director of the company w.e.f. 25-Jun-2022 2.appointment of NIRAV PATEL AND ASSOCIATES as Statutory Auditor of the company w.e.f. 27-Jun-2022 3.Appointed M/s. Jalan Alkesh & Associates, Practising Company Secretaries, Ahmedabad as Scrutiniser for the annual general meeting for the year ended on 31st March, 2022 4.appointment of KEVAL PONKIYA AND ASSOCIATES as Internal Auditor of the company w.e.f. 27-Jun-2022 5.Reappointment of Mr. Shalin Bharatbhai Chokshi as a Whole Time Director of the Company with effect from 4th December, 2022. 6.Re-appointment of SHALIN PATEL as Managing Director of the company w.e.f. 04-Dec-2022 7.re-appointment of JALAN ALKESH AND ASSOCIATES as Secretarial Auditor of the company (As Per NSE Announcement Dated on 27.06.2022)
17-May-2022 26-May-2022 Arvee Laboratories (India) Limited has informed the Exchange about Board Meeting to be held on 26-May-2022 to consider financial statements for the period ended March 2022 and Other business matters Arvee Laboratories (India) Limited has informed the Exchange about Board Meeting held on 26-May-2022 to consider financial statements for the period ended March 2022 and Other business matters.The Company has also appointed Mrs. Shalini Hitesh Jalan as Independent Director. (As Per NSE Announcement Dated on 26/05/2022)
28-Jan-2022 08-Feb-2022 To consider and approve the financial results for the period ended December 31, 2021 and other business matters
12-Nov-2021 12-Nov-2021 Arvee Laboratories (India) Limited has informed the Exchange regarding Board meeting held on November 12, 2021. The Board has approved the results for the period ended on 30th September, 2021. Limited review report for the period ended on 30th September, 2021 is enclosed.Statement of related party transaction is also enclosed.
06-Jul-2021 17-Jul-2021 To consider and approve the financial results for the period ended Jun 30, 2021 and other business matters as stated vide letter dated 6th July, 2021 Arvee Laboratories (India) Limited has informed the Exchange regarding Board meeting held on July 17, 2021. (As per NSE Announcement Dated on 17/07/2021)
08-Jun-2021 17-Jun-2021 To consider and approve the financial results for the period ended March 31, 2021 and other business matters Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2021. (As per NSE Announcement Dated on 17/06/2021)
1 2